$113 Million is the total value of Birchview Capital, LP's 0 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 30.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $43,800,000 | -12.4% | 785,785 | +0.9% | 38.85% | +6.9% |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INC | $18,274,000 | -50.5% | 2,193,795 | +0.5% | 16.21% | -39.6% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $6,405,000 | +8.3% | 74,000 | +34.5% | 5.68% | +32.2% |
| QDEL | QUIDEL CORP | $4,777,000 | +30.3% | 48,844 | 0.0% | 4.24% | +59.0% | |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $3,887,000 | +548.9% | 92,000 | +557.1% | 3.45% | +692.6% |
| BIIB | Buy | BIOGEN INC | $3,480,000 | +134.5% | 11,000 | +120.0% | 3.09% | +186.1% |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $2,843,000 | +85.3% | 148,000 | +85.0% | 2.52% | +126.2% |
| BMYRT | Buy | BMY CVR RTS 03/31/21right | $2,686,000 | +27.5% | 706,848 | +1.0% | 2.38% | +55.6% |
| VRML | VERMILLION INC | $2,682,000 | +2.8% | 3,221,933 | 0.0% | 2.38% | +25.4% | |
| UTHR | Buy | UNITED THERAPEUTICS CORP | $1,707,000 | +288.0% | 18,000 | +260.0% | 1.51% | +373.1% |
| XLRN | ACCELERON PHARMA INC | $1,678,000 | +69.5% | 18,672 | 0.0% | 1.49% | +106.7% | |
| OXFD | OXFORD IMMUNOTEC GLOBAL PLC | $1,577,000 | -44.2% | 170,303 | 0.0% | 1.40% | -31.9% | |
| GILD | New | GILEAD SCIENCES INC | $1,495,000 | – | 20,000 | +100.0% | 1.33% | – |
| CFRX | Sell | CONTRAFECT CORP | $1,473,000 | -16.1% | 255,700 | -91.0% | 1.31% | +2.4% |
| MASI | MASIMO CORP | $1,417,000 | +12.1% | 8,000 | 0.0% | 1.26% | +36.8% | |
| CCXI | Buy | CHEMOCENTRYX INC | $1,205,000 | +21.8% | 30,000 | +20.0% | 1.07% | +48.7% |
| EPZM | New | EPIZYME INC | $931,000 | – | 60,000 | +100.0% | 0.83% | – |
| ARNA | ARENA PHARMACEUTICALS INC | $924,000 | -7.5% | 22,000 | 0.0% | 0.82% | +12.9% | |
| VNDA | VANDA PHARMACEUTICALS INC | $829,000 | -36.9% | 80,000 | 0.0% | 0.74% | -23.0% | |
| ALBO | ALBIREO PHARMA INC | $786,000 | -35.6% | 48,000 | 0.0% | 0.70% | -21.4% | |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $720,000 | -43.1% | 180,000 | +205.1% | 0.64% | -30.5% |
| HROW | HARROW HEALTH INC | $688,000 | -50.9% | 180,000 | 0.0% | 0.61% | -40.1% | |
| IMGN | Buy | IMMUNOGEN INC | $648,000 | -29.5% | 190,000 | +5.6% | 0.58% | -13.9% |
| EQM | EQM MIDSTRM PRTNERS LP LTDunit ltd partn | $605,000 | -60.6% | 51,250 | 0.0% | 0.54% | -51.9% | |
| ARVN | Sell | ARVINAS INC | $604,000 | -51.0% | 15,000 | -50.0% | 0.54% | -40.2% |
| CORT | CORCEPT THERAPEUTICS INC | $594,000 | -1.8% | 50,000 | 0.0% | 0.53% | +19.8% | |
| ODT | ODONATE THERAPEUTICS INC | $552,000 | -14.9% | 20,000 | 0.0% | 0.49% | +3.8% | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | $523,000 | -49.2% | 8,300 | 0.0% | 0.46% | -38.0% | |
| SLNO | Sell | SOLENO THERAPEUTICS INC | $480,000 | -68.0% | 201,499 | -60.5% | 0.43% | -61.0% |
| STOK | New | STOKE THERAPEUTICS INC | $458,000 | – | 20,000 | +100.0% | 0.41% | – |
| GTHX | G1 THERAPEUTICS INC | $441,000 | -58.3% | 40,000 | 0.0% | 0.39% | -49.1% | |
| IFRX | New | INFLARX NV | $420,000 | – | 110,000 | +100.0% | 0.37% | – |
| XNCR | XENCOR INC | $368,000 | -13.0% | 12,300 | 0.0% | 0.33% | +6.2% | |
| FOLD | AMICUS THERAPEUTICS INC | $351,000 | -5.1% | 38,000 | 0.0% | 0.31% | +15.6% | |
| BHVN | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $340,000 | -37.5% | 10,000 | 0.0% | 0.30% | -23.5% | |
| PGNY | PROGYNY INC | $318,000 | -22.8% | 15,000 | 0.0% | 0.28% | -5.7% | |
| TBIO | New | TRANSLATE BIO INC | $299,000 | – | 30,000 | +100.0% | 0.26% | – |
| VYGR | VOYAGER THERAPEUTICS INC | $274,000 | -34.6% | 30,000 | 0.0% | 0.24% | -20.3% | |
| PXD | PIONEER NATURAL RESOURCES CO | $267,000 | -53.6% | 3,800 | 0.0% | 0.24% | -43.3% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $230,000 | -56.9% | 30,000 | 0.0% | 0.20% | -47.4% | |
| APLS | APELLIS PHARMACEUTICALS INC | $214,000 | -12.7% | 8,000 | 0.0% | 0.19% | +6.7% | |
| DRNA | DICERNA PHARMACEUTICALS INC | $184,000 | -16.4% | 10,000 | 0.0% | 0.16% | +1.9% | |
| TGTX | TG THERAPEUTICS INC | $148,000 | -11.4% | 15,000 | 0.0% | 0.13% | +8.3% | |
| YTEN | Sell | YIELD10 BIOSCIENCE INC | $71,000 | -45.4% | 18,952 | -97.5% | 0.06% | -33.0% |
| WKHS | WORKHORSE GROUP INC | $45,000 | -40.8% | 25,000 | 0.0% | 0.04% | -27.3% | |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $40,000 | -42.0% | 20,000 | 0.0% | 0.04% | -30.0% | |
| LTHM | Exit | LIVENT CORP | $0 | – | -10,000 | -100.0% | -0.06% | – |
| CLR | Exit | CONTINENTAL RESOURCES INC | $0 | – | -6,000 | -100.0% | -0.15% | – |
| ECA | Exit | ENCANA CORP | $0 | – | -49,550 | -100.0% | -0.17% | – |
| VCYT | Exit | VERACYTE INC | $0 | – | -10,767 | -100.0% | -0.22% | – |
| LXRX | Exit | LEXICON PHARMACEUTICALS INC | $0 | – | -80,000 | -100.0% | -0.24% | – |
| SIEN | Exit | SIENTRA INC | $0 | – | -40,000 | -100.0% | -0.26% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -30,000 | -100.0% | -0.34% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -20,000 | -100.0% | -0.49% | – |
| MYGN | Exit | MYRIAD GENETICS INC | $0 | – | -30,000 | -100.0% | -0.59% | – |
| T107PS | Exit | WRIGHT MEDICAL GROUP NV | $0 | – | -30,000 | -100.0% | -0.66% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -80,000 | -100.0% | -0.88% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.